The flemish environment and health study (FLEHS) - Second survey (2007-2011): Establishing reference values for biomarkers of exposure in the flemish population

Issues in Toxicology

Volumn 1, Issue , 2012, Pages 135-165

  Schoeters, Greet ^a,b   Colles, Ann ^a   Hond, Elly Den ^a   Croes, Kim ^c   Vrijens, Jan ^c   Baeyens, Willy ^c   Nelen, Vera ^d   Van De Mieroop, Els ^d   Covaci, Adrian ^b   Bruckers, Liesbeth ^e   Van Larebeke, Nicolas ^f   Sioen, Isabelle ^f   Morrens, Bert ^b   Loots, Ilse ^b  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d Provincial Institute of Hygiene   (Belgium)

^e HASSELT UNIVERSITY   (Belgium)

^f GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892677195     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: None     Document Type: Article

References (119)

1. Het Belgisch Staatsblad, Prevention Decree, Art. 51 y1 Flemish Authority, Het Belgisch Staatsblad, 2004.
2. E. Den Hond, H. Chovanova, B. Dumez, H. Keune, G. Schoeters, C. Teughels and K. Van Campenhout, Human biomonitoring in Flanders: some aspects related to study design, future, communication and ethics., Bulletin épidé miologique hebdomadaire, 2009, Special edition, 9-13.
3. C. Schroijen, W. Baeyens, G. Schoeters, E. Den Hond, G. Koppen, L. Bruckers, V. Nelen, E. Van De Mieroop, M. Bilau, A. Covaci, H. Keune, I. Loots, J. Kleinjans, W. Dhooge and N. Van Larebeke, Internal exposure to pollutants measured in blood and urine of Flemish adolescents in function of area of residence, Chemosphere, 2008, 71, 1317-1325.
4. A. Covaci and P. Schepens, Improved determination of selected POPs in human serum by solid phase disk extraction and GC-MS, Chemosphere, 2001, 43.
5. A. Covaci and S. Voorspoels, Optimization of the determination of polybrominated diphenyl ethers in human serum using solid-phase extraction and gas chromatography-electron capture negative ionization mass spectrometry, J. Chromatogr. B, 2005, 827.
6. G. Koppen, A. Covaci, R. Van Cleuvenbergen, P. Schepens, G. Winneke, V. Nelen and G. Schoeters, Comparison of CALUX-TEQ values with PCB and PCDD/F measurements in human serum of the Flanders Environmental and Health Study (FLEHS), Toxicol. Letts., 2001, 123.
7. T. Geens, H. Neels and A. Covaci, Sensitive and selective method for the determination of bisphenol-A and triclosan in serum and urine as pentafluorobenzoatederivatives using GC-ECNI/MS, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877, 4042-4046.
8. M. J. Silva, A. R. Slakman, J. A. Reidy and J. L. Preau, Jr., A. R. Herbert, E. Samandar, L. L. Needham and A. M. Calafat, Analysis of human urine for fifteen phthalate metabolites using automated solidphase extraction, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2004, 805, 161-167.
9. O. Midasch, H. Drexler, N. Hart, M. W. Beckmann and J. Angerer, Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study, Int. Arch. Occup. Environ. Health, 2007, 80, 643-648.
10. O. Midasch, T. Schettgen and J. Angerer, Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population, Int. J. Hyg. Environ. Health, 2006, 209, 489-496.
11. J. Angerer and K. H. Schaller, Analyses of Hazardous Substances in Biological Materials, Wiley-VCH Verlag, Weinheim, 1998.
12. J. Hardt and J. Angerer, Determination of dialkyl phosphates in human urine using gas chromatography-mass spectrometry, J. Anal. Toxicol., 2000, 24, 678-684.
13. S. M. Hays, R. A. Becker, H. W. Leung, L. L. Aylward and D. W. Pyatt, Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective, Regul. Toxicol. Pharmacol., 2007, 47, 96-109.
14. S. M. Hays, L. L. Aylward, J. S. La Kind, M. J. Bartels, H. A. Barton, P. J. Boogaard, C. Brunk, S. Di Zio, M. Dourson, D. A. Goldstein, J. Lipscomb, M. E. Kilpatrick, D. Krewski, K. Krishnan, M. Nordberg, M. Okino, Y. M. Tan, C. Viau and J. W. Yager, Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop, Regul. Toxicol. Pharmacol., 2008, 51, S4-S15.
15. K. Becker, M. Müssig-Zufika, A. Conrad, A. Lüdecke, C. Schulz, M. Seiwert and M. Kolossa-Gehring, German Environmental Survey for Children 2003/06-GerES IV-Human Biomonitoring: Levels of selected chemicals in blood and urine of children in Germany, Umweltbundesambt, Dessau-Rosslau, 2008.
16. Centers for Disease Control and Prevention, Fourth National Report on Human Exposure to Environmental Chemicals, CDC, Atlanta, 2009.
17. World Health Organization, Environmental Health Criteria 165: Lead.-Task group on environmental health criteria for lead. World Health Organization, Geneva, 1995.
18. Centers for Disease Control and Prevention, Preventing Lead Poisoning in Young Children: a statement by the Centers for Disease Control, Atlanta, 1991.
19. P. Grandjean, Even low-dose lead exposure is hazardous, Lancet, 2010, 376, 855-856.
20. European Chemicals Bureau, Cadmium Metal and Cadmium Oxide. CAS No:7440-43-9 and CAS No:1306-19-0, EINECS No:231-152-8 and EINECS No:215-146-2. Summary Risk Assessment Report, 2008.
21. S. M. Hays, M. Nordberg, J. W. Yager and L. L. Aylward, Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9), Regul. Toxicol. Pharmacol., 2008, 51, S49-S56.
22. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Copper, Public Health Service, US Department of Health and Human Services, Atlanta, 2004.
23. J. Emsley, Manganese. Nature's Building Blocks: An A-Z Guide to the Elements, Oxford University Press, Oxford, UK, 2001.
24. J. G. Kaufman, Applications for Aluminium Alloys and Tempers: Introduction to aluminium alloys and tempers, ASM International, 2000.
25. L. A. Corathers, 2006 Minerals Yearbook: Manganese, United States Geological Survey, Washington DC, 2008.
26. L. A. Graham, A. R. Fout, K. R. Kuehne, J. L. White, B. Mookherji, F. M. Marks, G. P. A. Yap, L. N. Zakharov, A. L. Rheingold and D. Rabinovich, Manganese (I) poly (mercaptoimidazolyl) borate complexes: spectroscopic and structural characterization of MnH-B interactions in solution and in the solid state, Dalton Trans., 2005, 171-180.
27. R. M. Dell, Batteries: fifty years of materials development, Solid State Ionics, 2000, 134, 139-158.
28. A. A. Francis and C. Forsyth, Toxicity Profiles. Formal Toxicity Summary for Manganese, US Department of Energy, 1995.
29. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Thallium, Public Health Service, US Department of Health and Human Services, Atlanta, 1992.
30. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Arsenic, Public Health Service, US Department of Health and Human Services, Atlanta, 2005.
31. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Suppl. 7, Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs Volumes 1 to 42, IARC, Lyon, France, 1987.
32. J. Calderon, M. E. Navarro, M. E. Jimenez-Capdeville, M. A. Santos-Diaz, A. Golden, I. Rodriguez-Leyva, V. Borja-Aburto and F. Diaz-Barriga, Exposure to arsenic and lead and neuropsychological development in Mexican children, Environ. Res., 2001, 85, 69-76.
33. S. Y. Tsai, H. Y. Chou, H. W. The, C. M. Chen and C. J. Chen, The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence, Neurotoxicology, 2003, 24, 747-753.
34. J. C. Davey, J. E. Bodwell, J. A. Gosse and J. W. Hamilton, Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture, Toxicol. Sci., 2007, 98, 75-86.
35. Y. M. Hsueh, Y. L. Huang, C. C. Huang, W. L. Wu, H. M. Chen, M. H. Yang, L. C. Lue and C. J. Chen, Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan, J. Toxicol. Environ. Health A, 1998, 54, 431-444.
36. R. M. Brown, D. Newton, C. J. Pickford and J. C. Sherlock, Human metabolism of arsenobetaine ingested with fish, Hum. Exp. Toxicol., 1990, 9, 41-46.
37. D. A. Kalman, Dietary contributions to arsenic species in urine, World Health Organization, Geneva, 1987.
38. G. K. Tam and G. Lacroix, Dry ashing, hydride generation atomic absorption spectrometric determination of arsenic and selenium in foods, J. Assoc. Off. Anal. Chem., 1982, 65, 647-650.
39. S. M. Hays, L. L. Aylward, M. Gagne, A. Nong and K. Krishnan, Biomonitoring equivalents for inorganic arsenic, Regul. Toxicol. Pharmacol., 2010, 58, 1-9.
40. World Health Organization, Guidance for Identifying Populations at Risk from Mercury Exposure, UNEP DTIE Chemicals Branch and WHO Department of Food Safety, Zoonoses and Foodborne Diseases, Geneva, 2008.
41. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Mercury, US Department of Health and Human Services, Public Health Service, ATSDR, Atlanta, 1999.
42. International Programme on Chemical Safety, Environmental Health Criteria 118, Inorganic Mercury, World Health Organization, Geneva, 1991.
43. United Nations Environment Programme, Global Mercury Assessment, UNEP Chemicals Mercury Programme, 2002.
44. National Research Council, Toxicological Effects of Methylmercury, National Academy Press, Washington D. C., 2000.
45. United States Environmental Protection Agency, Mercury Study Report to Congress, Volume IV: Assessment of Exposure to Mercury in the United States, Office of Air Quality Planning and Standards and Office of Research and Development, Washington DC, 1997.
46. T. W. Clarkson, J. B. Hursh, P. R. Sager and T. L. M. Syversen, Mercury, in Biological Monitoring of Toxic Metals., ed. T. W. Clarkson, L. Friberg, G. F. Nordberg and P. R. Sager, Plenum Press, New York, 1988.
47. European Food Safety Authority, Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to mercury and methylmercury in food, EFSA J., 2004, 34, 1-14.
48. European Food Safety Authority, Opinion of the scientific panel on contaminants in the food chain on a request from the Commission related to the presence of non dioxin-like polychlorinated biphenyls (PCB) in feed and food, EFSA J., 2005, 284, 1-137.
49. Agency for Toxic Substances and Disease Registry, Toxicological Profile for DDT, DDE and DDD, Public Health Service, US Department of Health and Human Services, Atlanta, 2002.
50. European Food Safety Authority, Opinion of the scientific panel on contaminants in the food chain on a request from the Commission related to DDT as an undesirable substance in animal feed, EFSA J., 2006, 433, 1-69.
51. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 53. Occupational Exposures in Insecticide Application, and some Pesticides. Summary of Data Reported and Evaluation, IARC, Lyon, France, 1999.
52. B. A. Cohn, P. M. Cirillo, M. S. Wolff, P. J. Schwingl, R. D. Cohen, R. I. Sholtz, A. Ferrara, R. E. Christianson, B. J. van den Berg and P. K. Siiteri, DDT and DDE exposure in mothers and time to pregnancy in daughters, Lancet, 2003, 361, 2205-2206.
53. A. R. Greenlee, T. E. Arbuckle and P. H. Chyou, Risk factors for female infertility in an agricultural region, Epidemiology, 2003, 14, 429-436.
54. K. M. Curtis, D. A. Savitz, C. R. Weinberg and T. E. Arbuckle, The effect of pesticide exposure on time to pregnancy, Epidemiology, 1999, 10, 112-117.
55. C. J. de K. Westveer, V. E. te D. Heederik and K. R. Van, Time to pregnancy and occupational exposure to pesticides in fruit growers in The Netherlands, Occup. Environ. Med., 1994, 51, 693-699.
56. D. Whorton, R. M. Krauss, S. Marshall and T. H. Milby, Infertility in male pesticide workers, Lancet, 1977, 2, 1259-1261.
57. V. Daniel, W. Huber, K. Bauer, C. Suesal, C. Conradt and G. Opelz, Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodies, Environ. Health Perspect., 2001, 109, 173-178.
58. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluations of Carcinogenic Risks to Humans. Volume 79. Hexachlorobenzene. Summaries and Evaluations, IARC, Lyon, France, 2001.
59. L. L. Aylward, S. M. Hays, M. Gagne, A. Nong and K. Krishnan, Biomonitoring equivalents for hexachlorobenzene, Regul. Toxicol. Pharmacol., 2010, 58, 25-32.
60. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Chlorinated Dibenzo-p-Dioxins, Public Health Service, US Department of Health and Human Services, Atlanta, 1998.
61. Scientific Committee on Food, Opinion of the SCF on the risk assessment of dioxins and dioxin-like PCBs in Food, European Commission, 2011.
62. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 69. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans, IARC, Lyon, France, 2011.
63. C. A. de Wit, An overview of brominated flame retardants in the environment, Chemosphere, 2002, 46, 583-624.
64. P. O. Darnerud, Toxic effects of brominated flame retardants in man and in wildlife, Environ. Int., 2003, 29, 841-853.
65. L. S. Birnbaum and D. F. Staskal, Brominated flame retardants: cause for concern?, Environ. Health Perspect., 2004, 112, 9-17.
66. European Food Safety Authority, Scientific Opinion on Bisphenol A: evaluation of a study investigating its neurodevelopmental toxicity, review of recent scientific literature on its toxicity and advice on the Danish risk assessment of Bisphenol A., EFSA J., 2010, 8.
67. F. S. Vom Saal and C. Hughes, An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment, Environ. Health Perspect., 2005, 113, 926-933.
68. K. Krishnan, M. Gagne, A. Nong, L. L. Aylward and S. M. Hays, Biomonitoring Equivalents for bisphenol A (BPA), Regul. Toxicol. Pharmacol., 2010, 58, 18-24.
69. L. E. Gray, Jr., J. Ostby, J. Furr, M. Price, D. N. Veeramachaneni and L. Parks, Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat, Toxicol. Sci., 2000, 58, 350-365.
70. K. Marsee, T. J. Woodruff, D. A. Axelrad, A. M. Calafat and S. H. Swan, Estimated daily phthalate exposures in a population of mothers of male infants exhibiting reduced anogenital distance, Environ. Health Perspect., 2006, 114, 805-809.
71. R. Hauser and A. M. Calafat, Phthalates and human health, Occup. Environ. Med., 2005, 62, 806-818.
72. J. Weuve, B. N. Sanchez, A. M. Calafat, T. Schettler, R. A. Green, H. Hu and R. Hauser, Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites, Environ. Health Perspect., 2006, 114, 1424-1431.
73. R. Hauser, J. D. Meeker, S. Duty, M. J. Silva and A. M. Calafat, Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites, Epidemiology, 2006, 17, 682-691.
74. S. H. Swan, K. M. Main, F. Liu, S. L. Stewart, R. L. Kruse, A. M. Calafat, C. S. Mao, J. B. Redmon, C. L. Ternand, S. Sullivan and J. L. Teague, Decrease in anogenital distance among male infants with prenatal phthalate exposure, Environ. Health Perspect., 2005, 113, 1056-1061.
75. J. J. Jaakkola and T. L. Knight, The role of exposure to phthalates from polyvinyl chloride products in the development of asthma and allergies: a systematic review and meta-analysis, Environ. Health Perspect., 2008, 116, 845-853.
76. L. L. Aylward, S. M. Hays, M. Gagne and K. Krishnan, Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP), Regul. Toxicol. Pharmacol., 2009, 55, 259-267.
77. K. Kannan, S. Corsolini, J. Falandysz, G. Fillmann, K. S. Kumar, B. G. Loganathan, M. A. Mohd, J. Olivero, W. N. Van, J. H. Yang and K. M. Aldoust, Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries, Environ. Sci. Technol., 2004, 38, 4489-4495.
78. European Food Safety Authority, Opinion of the Scientific Panel on Contaminants in the Food Chain on perfluorooctane sulfonate (PFOS), perfluorooactnoic acid (PFOA) and their salts, EFSA J., 2008, 653, 1-131.
79. U. Berger, U. Jarnberg and R. Kallenborn, Perfluorinated alkylated substances (PFAS) in the European Nordic environment, Organohalogen Comp., 2004, 66, 4046-4052.
80. K. E. Holmstrom, U. Jarnberg and A. Bignert, Temporal trends of PFOS and PFOA in guillemot eggs from the Baltic Sea, 1968-2003, Environ. Sci. Technol., 2005, 39, 80-84.
81. C. Lau, K. Anitole, C. Hodes, D. Lai, A. Pfahles-Hutchens and J. Seed, Perfluoroalkyl acids: a review of monitoring and toxicological findings, Toxicol. Sci., 2007, 99, 366-394.
82. M. K. So, N. Yamashita, S. Taniyasu, Q. Jiang, J. P. Giesy, K. Chen and P. K. Lam, Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China, Environ. Sci. Technol., 2006, 40, 2924-2929.
83. W. Hu, P. D. Jones, B. L. Upham, J. E. Trosko, C. Lau and J. P. Giesy, Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo, Toxicol. Sci., 2002, 68, 429-436.
84. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Polycyclic Aromatic Hydrocarbons, Public Health Service, US Department of Health and Human Services, Atlanta, 1995.
85. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 92: Some Non-heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures, World Health Organization, Lyon, France, 2010.
86. World Health Organization, Environmental Health Criteria 202: Selected non-heterocyclic polycyclic aromatic hydrocarbons, International Programme on Chemical Safety, World Health Organization, Geneva, 1998.
87. Scientific Committee on Food, Opinion of the Scientific Committee on Food on the Risks to Human Health of Polycyclic Aromatic Hydrocarbons in Food, European Commission, Health and Consumer Protection Directorate-General, Brussels, 2002.
88. Agency for Toxic Substances and Disease Registry, Toxicological Profile for Benzene, Public Health Service, US Department of Health and Human Services, Atlanta, 2007.
89. European Chemicals Bureau, Benzene. Summary Risk Assessment Report, Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Dortmund, Germany, 2007.
90. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluations of Carcinogenic Risks to Humans. Volume 29: Some industrial chemicals and dyestuffs, IARC, Lyon, France, 1998.
91. P. J. Boogaard and N. J. van Sittert, Suitability of S-phenyl mercapturic acid and trans-trans-muconic acid as biomarkers for exposure to low concentrations of benzene, Environ. Health Perspect., 1996, 104(Suppl 6), 1151-1157.
92. O. Inoue, K. Seiji, H. Nakatsuka, T. Watanabe, S. N. Yin, G. L. Li, S. X. Cai, C. Jin and M. Ikeda, Urinary t, t-muconic acid as an indicator of exposure to benzene, Br. J. Indust. Med., 1989, 46, 122-127.
93. R. Recio, G. Ocampo-Gomez, J. Moran-Martinez, V. Borja-Aburto, M. Lopez-Cervante, M. Uribe, L. Torres-Sanchez and M. E. Cebrian, Pesticide exposure alters follicle-stimulating hormone levels in Mexican agricultural workers, Environ. Health Perspect., 2005, 113, 1160-1163.
94. C. Padungtod, B. L. Lasley, D. C. Christiani, L. M. Ryan and X. Xu, Reproductive hormone profile among pesticide factory workers, J. Occup. Environ. Med., 1998, 40, 1038-1047.
95. E. Straube, W. Straube, E. Kruger, M. Bradatsch, M. Jacob-Meisel and H. J. Rose, Disruption of male sex hormones with regard to pesticides: pathophysiological and regulatory aspects, Toxicol. Lett., 1999, 107, 225-231.
96. M. H. Bhatt, M. A. Elias and A. K. Mankodi, Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases, Neurology, 1999, 52, 1467-1471.
97. F. Kamel and J. A. Hoppin, Association of pesticide exposure with neurologic dysfunction and disease, Environ. Health Perspect., 2004, 112, 950-958.
98. D. G. Le Couteur, A. J. McLean, M. C. Taylor, B. L. Woodham and P. G. Board, Pesticides and Parkinson's disease, Biomed. Pharmacother., 1999, 53, 122-130.
99. J. A. Hoppin, D. M. Umbach, S. J. London, M. C. Alavanja and D. P. Sandler, Chemical predictors of wheeze among farmer pesticide applicators in the Agricultural Health Study, Am. J. Respir. Crit Care Med., 2002, 165, 683-689.
100. B. Eskenazi, A. Bradman and R. Castorina, Exposures of children to organophosphate pesticides and their potential adverse health effects, Environ. Health Perspect., 1999, 107(Suppl 3), 409-419.
101. P. J. Landrigan, L. Claudio, S. B. Markowitz, G. S. Berkowitz, B. L. Brenner, H. Romero, J. G. Wetmur, T. D. Matte, A. C. Gore, J. H. Godbold and M. S. Wolff, Pesticides and inner-city children: exposures, risks, and prevention, Environ. Health Perspect., 1999, 107(Suppl 3), 431-437.
102. F. P. Perera, V. Rauh, W. Y. Tsai, P. Kinney, D. Camann, D. Barr, T. Bernert, R. Garfinkel, Y. H. Tu, D. Diaz, J. Dietrich and R. M. Whyatt, Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population, Environ. Health Perspect., 2003, 111, 201-205.
103. European Chemicals Bureau, European Union Risk Assessment Report 1, 4-dichlorobenzene. 1st Priority List Volume 48, European Communities, France, 2004.
104. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals. Volume 73: Dichlorobenzenes, IARC, Lyon, France, 1999.
105. F. Balk and R. A. Ford, Environmental risk assessment for the polycyclic musks AHTN and HHCB in the EU. I. Fate and exposure assessment, Toxicol. Lett., 1999, 111, 57-79.
106. European Chemicals Bureau, European Union Risk Assessment Report 5-tert-butyl-2, 4, 6-trinitro-m-xylene. 3rd Priority List Volume 55, European Communities, The Netherlands, 2005.
107. N. Bitsch, C. Dudas, W. Korner, K. Failing, S. Biselli, G. Rimkus and H. Brunn, Estrogenic activity of musk fragrances detected by the E-screen assay using human mcf-7 cells, Arch. Environ. Contam. Toxicol., 2002, 43, 257-264.
108. R. H. Schreurs, M. E. Quaedackers, W. Seinen and B. van der Burg, Transcriptional activation of estrogen receptor ERalpha and ERbeta by polycyclic musks is cell type dependent, Toxicol. Appl. Pharmacol., 2002, 183, 1-9.
109. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluations of Carcinogenic Risks to Humans. Volume 65. Printing Processes and Printing Inks, Carbon Black and some Nitro Compounds, IARC, Lyon, France, 1996.
110. A. Glaser, The ubiquitous triclosan: a common antibacterial agent exposed, Pesticides and You, 2004, 24, 12-17.
111. United States Environmental Protection Agency, Reregistration Eligibility Decision for Triclosan, US EPA, 2008.
112. Scientific Committee on Consumer Safety, Opinion on Triclosan Antimicrobial Resistance, European Commission Scientific Committees, Brussels, Belgium, 2010.
113. K. Krishnan, M. Gagne, A. Nong, L. L. Aylward and S. M. Hays, Biomonitoring Equivalents for triclosan, Regul. Toxicol. Pharmacol., 2010, 58, 10-17.
114. M. Kawaguchi, R. Ito, H. Honda, N. Endo, N. Okanouchi, K. Saito, Y. Seto and H. Nakazawa, Determination of urinary triclosan by stir bar sorptive extraction and thermal desorption-gas chromatography-mass spectrometry, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2008, 875, 577-580.
115. European Food Safety Authority, Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission related to parahydroxybenzoates (E214-219), EFSA J., 2004, 83, 1-26.
116. D. Miller, B. B. Wheals, N. Beresford and J. P. Sumpter, Estrogenic activity of phenolic additives determined by an in vitro yeast bioassay, Environ. Health Perspect., 2001, 109, 133-138.
117. A. M. Vinggaard, W. Korner, K. H. Lund, U. Bolz and J. H. Petersen, Identification and quantification of estrogenic compounds in recycled and virgin paper for household use as determined by an in vitro yeast estrogen screen and chemical analysis, Chem. Res. Toxicol., 2000, 13, 1214-1222.
118. International Agency for Research on Cancer (IARC), IARC Monographs on the Evaluations of Carcinogenic Risks to Humans. Volume 83. Tobacco smoke and involuntary smoking, IARC, Lyon, France, 2002.
119. World Health Organization, International Consultation on Environmental Tobacco Smoke (ETS) and Child Health, World Health Organization, Geneva, 1999.